Koru Medical Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

It is fourth time lucky for Supernus Pharmaceuticals, as its Parkinson’s specialist finally receives US approval for Onapgo ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Delivery of i.v. medications via infusion devices has traditionally not been a major concern for pharmacists. The introduction of smart infusion technology has changed that paradigm by requiring ...

As promising as these drugs are, they’re not always easy to access. Leqembi and Kisunla are given as an intravenous (IV) infusion, meaning patients and caretakers often must travel to specialty health ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

Specialty Infusion Center provides treatment options for certain autoimmune diseases outside of a hospital setting.